“A Four-Way, Cross-Over Design, Randomized, Double-Blinded, Placebo-&Active-Controlled Study for the Evaluation of the Effect of a Supratherapeutic Dose of Sofpironium Bromide Gel, 15% Applied Topically on the QT QTc Intervals in Adult Healthy Volunteers”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s109. Accessed May 10, 2025. https://skin.dermsquared.com/skin/article/view/1082.